These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 12860294)
1. 14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid. Ito Y; Miyoshi E; Uda E; Yoshida H; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A Cancer Lett; 2003 Jun; 196(1):87-91. PubMed ID: 12860294 [TBL] [Abstract][Full Text] [Related]
2. 14-3-3 sigma possibly plays a constitutive role in papillary carcinoma, but not in follicular tumor of the thyroid. Ito Y; Miyoshi E; Uda E; Yoshida H; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A Cancer Lett; 2003 Oct; 200(2):161-6. PubMed ID: 14568170 [TBL] [Abstract][Full Text] [Related]
3. Expression of Jun activation domain-binding protein 1 and p27 (Kip1) in thyroid medullary carcinoma. Ito Y; Yoshida H; Nakamura Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A Pathology; 2005 Jun; 37(3):216-9. PubMed ID: 16175894 [TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma. Ahn J; Hong SA; Lee SE; Kim J; Oh YS; Park SJ; Chung YJ Endocr J; 2009; 56(5):707-13. PubMed ID: 19461157 [TBL] [Abstract][Full Text] [Related]
5. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression. Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612 [TBL] [Abstract][Full Text] [Related]
6. Expression and cellular localization of p8 protein in thyroid neoplasms. Ito Y; Yoshida H; Motoo Y; Miyoshi E; Iovanna JL; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A Cancer Lett; 2003 Nov; 201(2):237-44. PubMed ID: 14607339 [TBL] [Abstract][Full Text] [Related]
7. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Shintani S; Li C; Mihara M; Hino S; Nakashiro K; Hamakawa H Oncology; 2003; 65(4):355-62. PubMed ID: 14707456 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247 [TBL] [Abstract][Full Text] [Related]
9. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [TBL] [Abstract][Full Text] [Related]
10. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512 [TBL] [Abstract][Full Text] [Related]
11. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma. Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma. Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A Oncology; 2003; 64(1):83-9. PubMed ID: 12457035 [TBL] [Abstract][Full Text] [Related]
15. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid. Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683 [TBL] [Abstract][Full Text] [Related]
16. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606 [TBL] [Abstract][Full Text] [Related]
17. Delta Np73 expression in thyroid neoplasms originating from follicular cells. Ito Y; Uramoto H; Funa K; Yoshida H; Jikuzono T; Asahi S; Higashiyama T; Tomoda C; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A Pathology; 2006 Jun; 38(3):205-9. PubMed ID: 16753740 [TBL] [Abstract][Full Text] [Related]
18. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer. Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548 [TBL] [Abstract][Full Text] [Related]
19. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies. Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010 [TBL] [Abstract][Full Text] [Related]
20. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma. Ito Y; Arai K; Ryushi ; Nozawa ; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A Pathol Res Pract; 2005; 201(8-9):551-6. PubMed ID: 16259107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]